Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

Abstract Background Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulations changed to allow community-based prescribing and supply of clozapin...

Full description

Bibliographic Details
Main Authors: Bethany Wilson, Sara S. McMillan, Amanda J. Wheeler
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Clozapine
Community pharmacy
Schizophrenia
Australia
Treatment burden
Online Access:http://link.springer.com/article/10.1186/s40545-019-0180-3

Internet

http://link.springer.com/article/10.1186/s40545-019-0180-3

Similar Items